| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |